Clinical Trials Directory

A Phase II Trial of Hippocampal Avoidance During Whole Brain Radiotherapy for Brain Metastases

RATIONALE: Radiation therapy uses high energy x-rays to kill tumor cells. PURPOSE: This phase II trial is studying how well avoiding the hippocampus during whole-brain radiation therapy works in treating patients with brain metastases.

Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.

Investigator(s):

Intervention(s):

  • other : questionnaire administration
  • other : laboratory biomarker analysis
  • procedure : cognitive assessment
  • procedure : quality-of-life assessment
  • radiation : whole-brain radiation therapy
  • radiation : intensity-modulated radiation therapy

Phase: Phase 2

Eligibility

Ages Eligible For Study:

18 Years - 120 Years

External Links

Explore related trials

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Jacob Wynne
6507238843
Not Recruiting

Footer Links: